Overview

Behavior Enhances Drug Reduction of Incontinence (BE-DRI)

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.
Phase:
N/A
Details
Lead Sponsor:
HealthCore-NERI
New England Research Institutes
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Treatments:
Tolterodine Tartrate